Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 5 , Pages 484-500 , May 2009

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

,Accepted 1 November 2008.

References 

  1. The MTA Cooperative Group  . A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder . Arch Gen Psychiatry . 1999;56:1073–1086
  2. The MTA Cooperative Group  . Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder . Arch Gen Psychiatry . 1999;56:1088–1096
  3. Richters JE , Arnold LE , Jensen PS , et al.   The National Institute of Mental Health collaborative multisite Multimodal Treatment Study of Children with ADHD: I. background and rationale . J Am Acad Child Adolesc Psychiatry . 1995;34:987–1000
  4. The MTA Cooperative Group  . National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder . Pediatrics . 2004;113:754–761
  5. The MTA Cooperative Group  . National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment . Pediatrics . 2004;113:762–769
  6. Jensen PS , Arnold LE , Swanson JM , et al.   3-year follow-up of the NIMH MTA study . J Am Acad Child Adolesc Psychiatry . 2007;46:989–1002
  7. Swanson JM , Hinshaw SP , Arnold LE , et al.   Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses . J Am Acad Child Adolesc Psychiatry . 2007;46:1003–1014
  8. Swanson J , Arnold LE , Kraemer H , et al.  MTA Cooperative Group   Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children with ADHD (MTA): Part I: executive summary . J Atten Disord . 2008;12:4–14
  9. Swanson J , Arnold LE , Kraemer H , et al.  MTA Cooperative Group   Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children with ADHD (MTA): Part 2: supporting details . J Atten Disord . 2008;12:15–43
  10. Arnold LE , Abikoff HB , Cantwell DP , Conners CK , Elliott GR , Greenhill LL . NIMH collaborative Multimodal Treatment Study of Children with ADHD (MTA): design challenges and choices . Arch Gen Psychiatry . 1997;54:865–870
  11. Greenhill LL , Abikoff HB , Arnold LE , Cantwell DP , Conners CK , Elliott GR . Medication treatment strategies in the MTA: relevance to clinicians and researchers . J Am Acad Child Adolesc Psychiatry . 1996;35:1304–1313
  12. Greenhill LL , Swanson JM , Vitiello B , Davies M , Clevenger W , Wu M . Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration . J Am Acad Child Adolesc Psychiatry . 2001;40:180–187
  13. Hinshaw SP , March JS , Abikoff HB , et al.   Comprehensive assessment of childhood attention-deficit hyperactivity disorder in the context of a multisite, multimodal clinical trial . J Atten Disord . 1997;1:217–234
  14. Wells KC , Pelham WE , Kotkin RA , et al.   Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation . J Abnorm Child Psychol . 2000;28:483–505
  15. Shaffer D , Fisher P , Lucas CP , Dulcan MK , Schwab-Stone ME . NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISCIV): description, differences from previous versions, and reliability of some common diagnoses . J Am Acad Child Adolesc Psychiatry . 2000;39:28–38
  16. American Psychiatric Association  . Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (DSM-IV) . Washington: American Psychiatric Association; 1994;
  17. Molina BS , Flory K , Hinshaw SP , et al.   Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects . J Am Acad Child Adolesc Psychiatry . 2007;46:1028–1040
  18. Jensen P , Hoagwood K , Roper M , et al.   The services for children and adolescents parent interview (SCAPI): development and performance characteristics . J Am Acad Child Adolesc Psychiatry . 2004;43:1334–1344
  19. Hoagwood K , Jensen PS , Arnold LE , et al.   Reliability of the services for children and adolescents parent interview (SCAPI) . J Am Acad Child Adolesc Psychiatry . 2004;43:1345–1454
  20. Bird HR , Shaffer D , Fisher P , et al.   The Columbia Impairment Scale (CIS): pilot findings on a measure of global impairment for children and adolescents . Int J Methods Psychiatr Res . 1993;3:167–176
  21. Kovacs M . Manual: The Children's Depression Inventory . Toronto: Multi-Health Systems; 1995;
  22. March J , Conners C , Arnold LE , et al.   The multidimensional anxiety scale for children (MASC): confirmatory factor analysis in a pediatric ADHD sample . J Atten Disord . 1999;3:85–89
  23. Wechsler D . Wechsler Individual Achievement Test . San Antonio: Psychological Corporation; 1992;
  24. Gresham FM , Elliott SN . Social Skills Rating System–Parent, Teacher, and Child Forms . Circle Pines: American Guidance Systems; 1989;
  25. Robins LN , Cottler LB , Bucholz KK , Compton WM , North CS , Rourke KM . Diagnostic Interview Schedule for the DSM-IV (DIS-IV) . St Louis: Washington University School of Medicine; 2000;
  26. Beck AT , Ward C , Mendelson N , Mock J , Erbaugh J . An inventory for measuring depression . Arch Gen Psychiatry . 1961;4:53–63
  27. Beck AT , Epstein N , Brown G , Steer RA . An inventory for measuring clinical anxiety: psychometric properties . J Consult Clin Psychol . 1988;56:893–897
  28. Hedeker D , Gibbons RD . Longitudinal Data Analysis . New York: John Wiley & Sons; 2006;
  29. Cohen J . A power primer . Psych Bull . 1992;112:155–159
  30. Roberts BW , DelVecchio WF . The rank-order consistency of personality traits from childhood to old age: A quantitative review of longitudinal studies . Psych Bull . 2000;126:3–25
  31. Owens EB , Hinshaw SP , Kraemer HC , et al.   Which treatment for whom for ADHD? Moderators of treatment response in the MTA . J Consult Clin Psychol . 2003;71:540–552
  32. Abikoff H , Hechtman L , Kelin RG , et al.   Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment . J Am Acad Child Adolesc Psychiatry . 2004;43:802–811
  33. Swanson JM , Volkow ND . Psychopharmacology: Concepts and opinions about the use of stimulant medications . J Child Psychol Psychiatry . 2009;50:180–193
  34. Hart EL , Lahey BB , Loeber R , Applegate B , Green SM , Frick PJ . Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study . J Abnorm Child Psychol . 1995;23:729–749
  35. Hinshaw SP , Owens EB , Sami N , Fargeon S . Prospective follow-up of girls with attention-deficit/hyperactivity disorder into adolescence: evidence for continuing cross-domain impairment . J Consult Clin Psychol . 2006;74:489–499
  36. Mick E , Faraone SV , Biederman J . Age-dependent expression of attention deficit/hyperactivity symptoms . Psychiatr Clin North Am . 2004;27:215–224
  37. Ross RG . Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder . Am J Psychiatry . 2006;163:1149–1152
  38. Barkley RA , Fischer M , Edelbrock CS , Smallish L . The adolescent outcome of hyperactive children diagnosed by research criteria: an 8-year prospective follow-up study . J Am Acad Child Adolesc Psychiatry . 1990;29:546–557
  39. Bagwell CL , Molina BSG , Pelham WE , Hoza B . Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence . J Am Acad Child Adolesc Psychiatry . 2001;40:1285–1292
  40. Barkley RA . Attention-deficit hyperactivity disorder . In: A Handbook for Diagnosis and Treatment . 3rd ed.. New York: The Guilford Press; 2005;
  41. Gordon M , Antshel K , Faraone S , et al.   Symptoms versus impairment. The case for respecting DSM-IV's Criterion D . J Atten Disord . 2006;9:465–475
  42. Pelham WE , Fabiano GA , Massetti GM . Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents . J Clin Child Adolesc Psychol . 2005;34:449–476
  43. Smith BH , Barkley RA , Shapiro CJ . Attention-deficit/hyperactivity disorder . In:  Mash EJ ,  Barkley RA editor. Treatment of Childhood Disorders . 3rd ed.. New York: The Guilford Press; 2006;p. 65–136
  44. Barkley RA , Fischer M , Smallish L , Fletcher KE . Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study . Pediatrics . 2003;111:97–109
  45. Visser SN , Lesesne CA , Perou R . National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder . Pediatrics . 2007;119:S99–S106
  46. Leslie LK , Wolraich ML . ADHD service use patterns in youth . J Pediatr Psychol . 2007;32:695–710
  47. DuPaul G , Power TJ . Improving school outcomes for students with ADHD: using the right strategies in the context of the right relationships . J Atten Disord . 2008;11:519–521
  48. Evans SW , White C , Sibley M , Barlow E . School-based mental health treatment of children and adolescents with attention deficit hyperactivity disorder . In:  Evans SW ,  Weist MD ,  Serpell ZN editor. Advances in School-Based Mental Health Interventions. Best Practices and Program Models . Volume II: Kingston: Civic Research Institute; 2007;p. 1–20
  49. Conduct Problems Prevention Research Group (2007)  . Fast track randomized controlled trial to prevent externalizing psychiatric disorders: findings from grades 3 to 9 . J Am Acad Child Adolesc Psychiatry . 2007;46:1250–1262

 The work reported was supported by cooperative agreement grants and contracts from the National Institute of Mental Health to the following: University of California, Berkeley: U01 MH50461, N01MH12009, and HHSN271200800005-C; Duke University: U01 MH50477, N01MH12012, and HHSN271200800009-C; University of California, Irvine: U01 MH50440, N01MH 12011, and HHSN271200800006-C; Research Foundation for Mental Hygiene (New York State Psychiatric Institute/Columbia University): U01 MH50467, N01 MH12007, and HHSN271200800007-C; Long Island-Jewish Medical Center U01 MH50453; New York University: N01MH12004 and HHSN271200800004-C; University of Pittsburgh: U01 MH50467, N01MH12010, and HHSN271200800008-C; and McGill University N01MH12008 and HHSN271200800003-C. The Office of Special Education Programs of the U.S. Department of Education, the Office of Juvenile Justice and Delinquency Prevention of the Justice Department, and the National Institute on Drug Abuse also participated in funding.The opinions and assertions contained in this report are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of Health and Human Services, the National Institutes of Health, or the National Institute of Mental Health.This article is the subject of an editorial by Dr. Philip L. Hazell in this issue.Clinical trial registration information—Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder. URL: http://www.clinicaltrials.gov. Unique identifier: NCT00000388.

PII: S0890-8567(09)60066-6

doi: 10.1097/CHI.0b013e31819c23d0

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 5 , Pages 484-500 , May 2009

Article Tools

* Image Usage & Resolution